Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine pharmacokinetics before and after Roux-en-Y gastric bypass
NL-OMON47961Withdrawn
- Sponsor
- Maasstad Ziekenhuis
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of venlafaxine in major depressive disorder (MDD), sponsored by Maasstad Ziekenhuis. Primary endpoint: Dose-corrected AUC. Planned start Nov 2019; status: withdrawn.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON47961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47961.